Health Care/Hospital

WellsCare signs in-store contract with b8ta for IASO

SEOUL, South Korea, Sept. 20, 2020 /PRNewswire/ -- WellsCare, a member company of theBorn2Global Centre, recently signed a store contract with b8ta, a famous American flagship store that is dedicated to innovative products. WellsCare has been an active member of the Born2Global Centre since 2019....

2020-09-20 20:00 2639

Preparation products of Yiling Pharma approved by FDA for launch in the US market

SHIJIAZHUANG, China, Sept. 19, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. announced on Friday that it had received the approvals of the Abbreviated New Drug Applications (ANDA) about Lisinopril Tablets and Acyclovir Capsules, from United States Food and Drug Administration (hereinafter ...

2020-09-19 19:14 2749

LUFTQI Launched a Crowdfunding Campaign for the LUFT Duo Filter-Free Air Purifier

TAOYUAN, Sept. 18, 2020 /PRNewswire/ -- Multiple fast-moving wildfires are continuing to burn across Califronia,Oregon and Washington, threatening people and homes. For essential worker commuters, including gig workers, this also means potential respiratory problems for those forced to drive unde...

2020-09-18 20:00 4650

MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer

PLANEGG/MUNICH, Germany and SHANGHAI, China, Sept. 17, 2020 /PRNewswire/ -- MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) and I-Mab (Nasdaq: IMAB) today jointly announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug applic...

2020-09-18 04:05 11026

Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis

SHANGHAI, Sept. 17, 2020 /PRNewswire/ -- Shanghai ChemPartner announced today the appointment ofSteven Yu, Ph.D. as Vice President of Regulated Bioanalysis at the company headquarters inShanghai, China. Dr. Yu has more than 15 years of experience in drug development and extensive expertise in...

2020-09-17 23:01 2460

Expanding Their Existing Strategic Collaboration, GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.

NANJING, China, Sept. 17, 2020 /PRNewswire/ -- On September 16th, 2020, GenScript ProBio and REMD Biotherapeutics Inc. (REMD) announced that REMD has licensed a bispecific antibody derived from the Single-domain antibody fused to Monoclonal Ab (SMAB) platform developed by GenScript ProBio. REMD i...

2020-09-17 22:00 2229

Happy Buy Reached Cooperation With Hive-Box, Testing Water In Community E-Commerce

NANPING, China, Sept. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that C'est La Vie Interactive Technology Co., Ltd ("CLV") , a subsidiary of Happy Buy, has signe...

2020-09-17 22:00 18226

Nebulyft® Skincare Device Set to Transform the Anti-Aging Landscape

IRVINE, Calif., Sept. 17, 2020 /PRNewswire/ -- Rebeccatech LLC is proud to introduce the Nebulyft®, World's 1st MicroRF anti-aging device that's truly non-intrusive. nebulyft anti-aging device by Rebeccatech The Nebulyft® skincare device...

2020-09-17 21:19 2036

China's Weifang, Ecuador's Guaranda ink ties and join hands in COVID-19 fight

WEIFANG, China, Sept. 17, 2020 /PRNewswire/ -- A video conference to share experiences of effective fight against the COVID-19 was held onSept. 11, when a signing ceremony of friendly and cooperative relations between Weifang City in China and Guaranda City in Ecuador also took place, according to...

2020-09-17 19:13 1580

Samsung Biologics signs development agreement with Panolos for solid tumor treatment

INCHEON, South Korea, Sept. 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat solid tumors. Under this agreement, Samsung Biologics will provide a full scope of its developm...

2020-09-17 08:43 2622

Less is more: Novel algorithm automatically removes poor-quality data to improve AI scalability

SAN FRANCISCO, Sept. 15, 2020 /PRNewswire/ -- AI Healthcare company Presagen has developed a novel technique that is able to automatically clean poor-quality data needed to train scalable and reliable Artificial Intelligence products.

2020-09-16 22:50 1962

ReTo Eco-Solutions Signs Cooperation Agreement to Build Large Scale Industrial Park and Elderly Wellness Town in Yangbi County

BEIJING, Sept. 16, 2020 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (the "Company," "we" or "ReTo") (NASDAQ: RETO), a one-stop, total technology solutions provider for the healthy improvement of ecological environments, today announced that it signed a cooperation agreement with the People's Govern...

2020-09-16 18:00 15254

Transcenta Successfully Scaled up the Continuous Perfusion Process and Completed GMP Manufacturing of a Novel Bispecific Antibody for Cancer Immunotherapy

SUZHOU, China and HANGZHOU, China, Sept. 15, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company, today announced success in scaling up the continuous perfusion process to 200L and completion of GMP production of a bispecific antibody for a Phase 1 clinical study.  "This is an impo...

2020-09-15 23:00 1705

Verkada Introduces Environmental Sensor to Provide Enhanced Visibility into Physical Spaces

Sensors seamlessly integrate with Verkada's enterprise video security and access control solutions to deliver real-time insights into buildings Verkada accelerates business growth in Q2 2020 with 65 percent quarter-over-quarter revenue growth amidst COVID-19 pandemic SAN MATEO, California, Sept....

2020-09-15 21:40 2564

Seoul Semiconductor Obtains Permanent Injunction against Philips Displays and Feit Light Bulbs

ANSAN, South Korea, Sept. 15, 2020 /PRNewswire/ -- Seoul Semiconductor Co., Ltd. ("Seoul") (KOSDAQ 046890), a leading global innovator of LED products and technology, announced that it has successfully obtained a permanent injunction in a patent infringement laws...

2020-09-15 19:00 2611

PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020

DAEJEON, South Korea, Sept. 14, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) today announced positive data from its two combination trials of olinvacimab, its leading clinical candidate in oncology, with MSD's pembrolizumab at the 13th Annual Meeting of the Korean Society of Medical O...

2020-09-14 20:00 1686

Coronavirus Breakthrough: Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient - Discharged Following Five Days of Treatment

TAIPEI and SAN DIEGO, Sept. 11, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced today that the first patient with severe COVID-19 demonst...

2020-09-12 08:34 3599

NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients

TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Genovate Biotech (TPEX:4130) subsidiary andTaiwan-based focused ultrasound (FUS) manufacturer NaviFUS Corporation is pleased to announce the start of its clinical trial (NCT04446416) for the combination of FUS plus bevacizumab therapy. Researchers at Linkou ...

2020-09-11 20:55 3947

Tottenham Acquisition I Limited Announces Filing of a Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Clene Nanomedicine, Inc.

NEW YORK, Sept. 10, 2020 /PRNewswire/ -- Tottenham Acquisition I Limited (Nasdaq: TOTA, TOTAU, TOTAW, TOTAR) ("Tottenham"), a publicly traded special purpose acquisition company, announced today that its subsidiary, Chelsea Worldwide Inc., has filed with the U.S. Securities and Exchange Commissio...

2020-09-10 20:56 21649

CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership

SUZHOU, China, Sept. 10, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), and Laekna Therapeutics Shanghai Co., Ltd. ("Laekna Therapeutics"), today announced a strategic collaboration agreement in Suzhou BioBAY for speedup of Immune Checkpoint Inhibitor (ICI) drug candidate to the clin...

2020-09-10 20:08 2160
1 ... 243244245246247248249 ... 277